{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:45:46Z","timestamp":1793151946969,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI14C2331"],"award-info":[{"award-number":["HI14C2331"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI14C3414"],"award-info":[{"award-number":["HI14C3414"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2018R1D1A1B07043696"],"award-info":[{"award-number":["NRF-2018R1D1A1B07043696"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>BCOR acts as a corepressor of BCL6, a potent oncogenic protein in cancers of the lymphoid lineage. We have found the recurrent somatic mutation of BCOR occurred in mature T-cell lymphoma (TCL). The role of BCOR mutation in lymphoid malignancies is unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Lymphoma patient samples were analyzed to identify missense mutations in BCOR using Sanger sequencing. Transfection, RNA interference, immunoprecipitation, western blotting, cell proliferation, cytokine assays and quantitative real-time PCR were employed to determine the functional relevance of the novel K607E mutation in BCOR. The significant transcriptional changes were analyzed by performing DNA microarray profiling in cells expressing BCOR K607E mutant.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>One hundred thirty-seven lymphoma patient samples were analyzed to identify K607E mutation of the BCOR gene. The BCOR K607E mutation was identified in 15 of 47 NK\/T cell lymphoma cases (31.9%), 2 of 18 angioimmunoblastic T-cell lymphoma cases (11.1%), 10 of 30 peripheral T-cell lymphoma, not otherwise specified cases (33.3%), and 13 of 42 diffuse large B-cell lymphoma cases (30.9%). Molecular analysis of BCOR K607E mutation revealed that compared to the wild-type BCOR, the mutant BCOR bound to the BCL6, PCGF1, and RING1B proteins with lesser affinity. Ectopic expression of BCOR K607E mutant significantly enhanced cell proliferation, AKT phosphorylation and the expression of interleukin-2 (IL-2) with up-regulated expression of<jats:italic>HOX<\/jats:italic>and S100 protein genes in T cells. BCOR silencing also significantly enhanced cell proliferation, AKT phosphorylation, and IL-2 production.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Functional analyses indicated that K607E mutation of BCOR is oncogenic in nature and can serve as a genetic marker of T-cell lymphoma.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12885-021-07806-8","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T21:02:52Z","timestamp":1611090172000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The mutation of BCOR is highly recurrent and oncogenic in mature T-cell lymphoma"],"prefix":"10.1186","volume":"21","author":[{"given":"Jin Hyun","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jawon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murim","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Seog","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Hyeh","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae Yong","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,19]]},"reference":[{"issue":"11","key":"7806_CR1","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","volume":"89","author":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma","year":"1997","unstructured":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood. 1997;89(11):3909\u201318.","journal-title":"Blood."},{"key":"7806_CR2","doi-asserted-by":"crossref","unstructured":"Tse E, Kwong Y-L. The diagnosis and management of NK\/T-cell lymphomas. J Hematol Oncol. 2017;10(1):85.","DOI":"10.1186\/s13045-017-0452-9"},{"issue":"17","key":"7806_CR3","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1182\/blood-2013-12-516245","volume":"123","author":"AJ Moskowitz","year":"2014","unstructured":"Moskowitz AJ, Lunning MA, Horwitz SM. How I treat the peripheral T-cell lymphomas. Blood. 2014;123(17):2636\u201344.","journal-title":"Blood."},{"issue":"25","key":"7806_CR4","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26(25):4124\u201330.","journal-title":"J Clin Oncol"},{"issue":"8","key":"7806_CR5","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1182\/blood-2011-11-391748","volume":"119","author":"RA Cairns","year":"2012","unstructured":"Cairns RA, Iqbal J, Lemonnier F, Kucuk C, de Leval L, Jais JP, et al. IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. Blood. 2012;119(8):1901\u20133.","journal-title":"Blood."},{"issue":"7","key":"7806_CR6","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1182\/blood-2012-02-408542","volume":"120","author":"F Lemonnier","year":"2012","unstructured":"Lemonnier F, Couronne L, Parrens M, Jais JP, Travert M, Lamant L, et al. Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters. Blood. 2012;120(7):1466\u20139.","journal-title":"Blood."},{"issue":"2","key":"7806_CR7","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/ng.2873","volume":"46","author":"T Palomero","year":"2014","unstructured":"Palomero T, Couronne L, Khiabanian H, Kim MY, Ambesi-Impiombato A, Perez-Garcia A, et al. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nat Genet. 2014;46(2):166\u201370.","journal-title":"Nat Genet"},{"issue":"2","key":"7806_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/ng.2872","volume":"46","author":"M Sakata-Yanagimoto","year":"2014","unstructured":"Sakata-Yanagimoto M, Enami T, Yoshida K, Shiraishi Y, Ishii R, Miyake Y, et al. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat Genet. 2014;46(2):171\u20135.","journal-title":"Nat Genet"},{"issue":"4","key":"7806_CR9","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/ng.2916","volume":"46","author":"HY Yoo","year":"2014","unstructured":"Yoo HY, Sung MK, Lee SH, Kim S, Lee H, Park S, et al. A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma. Nat Genet. 2014;46(4):371\u20135.","journal-title":"Nat Genet"},{"issue":"12","key":"7806_CR10","doi-asserted-by":"publisher","first-page":"e505","DOI":"10.3324\/haematol.2015.133074","volume":"100","author":"SH Lee","year":"2015","unstructured":"Lee SH, Kim JS, Kim J, Kim SJ, Kim WS, Lee S, et al. A highly recurrent novel missense mutation in CD28 among angioimmunoblastic T-cell lymphoma patients. Haematologica. 2015;100(12):e505\u20137.","journal-title":"Haematologica."},{"issue":"14","key":"7806_CR11","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1101\/gad.14.14.1810","volume":"14","author":"KD Huynh","year":"2000","unstructured":"Huynh KD, Fischle W, Verdin E, Bardwell VJ. BCoR, a novel corepressor involved in BCL-6 repression. Genes Dev. 2000;14(14):1810\u201323.","journal-title":"Genes Dev"},{"issue":"1","key":"7806_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri2217","volume":"8","author":"U Klein","year":"2008","unstructured":"Klein U, Dalla-Favera R. Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol. 2008;8(1):22\u201333.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"7806_CR13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ccr.2005.03.037","volume":"7","author":"G Cattoretti","year":"2005","unstructured":"Cattoretti G, Pasqualucci L, Ballon G, Tam W, Nandula SV, Shen Q, et al. Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice. Cancer Cell. 2005;7(5):445\u201355.","journal-title":"Cancer Cell"},{"issue":"1","key":"7806_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.patbio.2006.04.001","volume":"55","author":"F Jardin","year":"2007","unstructured":"Jardin F, Ruminy P, Bastard C, Tilly H. The BCL6 proto-oncogene: a leading role during germinal center development and lymphomagenesis. Pathol Biol (Paris). 2007;55(1):73\u201383.","journal-title":"Pathol Biol (Paris)"},{"issue":"3","key":"7806_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.coi.2013.05.003","volume":"25","author":"KL Bunting","year":"2013","unstructured":"Bunting KL, Melnick AM. New effector functions and regulatory mechanisms of BCL6 in normal and malignant lymphocytes. Curr Opin Immunol. 2013;25(3):339\u201346.","journal-title":"Curr Opin Immunol"},{"issue":"14","key":"7806_CR16","doi-asserted-by":"publisher","first-page":"6947","DOI":"10.1073\/pnas.93.14.6947","volume":"93","author":"CC Chang","year":"1996","unstructured":"Chang CC, Ye BH, Chaganti RS, Dalla-Favera R. BCL-6, a POZ\/zinc-finger protein, is a sequence-specific transcriptional repressor. Proc Natl Acad Sci U S A. 1996;93(14):6947\u201352.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"7806_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3324\/haematol.2011.057901","volume":"97","author":"E Tiacci","year":"2012","unstructured":"Tiacci E, Grossmann V, Martelli MP, Kohlmann A, Haferlach T, Falini B. The corepressors BCOR and BCORL1: two novel players in acute myeloid leukemia. Haematologica. 2012;97(1):3\u20135.","journal-title":"Haematologica."},{"issue":"7","key":"7806_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002814","volume":"3","author":"JA Wamstad","year":"2008","unstructured":"Wamstad JA, Corcoran CM, Keating AM, Bardwell VJ. Role of the transcriptional corepressor Bcor in embryonic stem cell differentiation and early embryonic development. PLoS One. 2008;3(7):e2814.","journal-title":"PLoS One"},{"issue":"18","key":"7806_CR19","doi-asserted-by":"publisher","first-page":"6880","DOI":"10.1128\/MCB.00630-06","volume":"26","author":"MD Gearhart","year":"2006","unstructured":"Gearhart MD, Corcoran CM, Wamstad JA, Bardwell VJ. Polycomb group and SCF ubiquitin ligases are found in a novel BCOR complex that is recruited to BCL6 targets. Mol Cell Biol. 2006;26(18):6880\u20139.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"7806_CR20","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1158\/1541-7786.MCR-13-0596","volume":"12","author":"Y Yamamoto","year":"2014","unstructured":"Yamamoto Y, Abe A, Emi N. Clarifying the impact of polycomb complex component disruption in human cancers. Mol Cancer Res. 2014;12(4):479\u201384.","journal-title":"Mol Cancer Res"},{"issue":"19","key":"7806_CR21","doi-asserted-by":"publisher","first-page":"17764","DOI":"10.18632\/oncotarget.3776","volume":"6","author":"S Lee","year":"2015","unstructured":"Lee S, Park HY, Kang SY, Kim SJ, Hwang J, Lee S, et al. Genetic alterations of JAK\/STAT cascade and histone modification in extranodal NK\/T-cell lymphoma nasal type. Oncotarget. 2015;6(19):17764\u201376.","journal-title":"Oncotarget."},{"issue":"5","key":"7806_CR22","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/gcc.22348","volume":"55","author":"A Dobashi","year":"2016","unstructured":"Dobashi A, Tsuyama N, Asaka R, Togashi Y, Ueda K, Sakata S, et al. Frequent BCOR aberrations in extranodal NK\/T-cell lymphoma, nasal type. Genes Chromosomes Cancer. 2016;55(5):460\u201371.","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"7806_CR23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0092-8674(02)01083-8","volume":"111","author":"DP Brazil","year":"2002","unstructured":"Brazil DP, Park J, Hemmings BA. PKB binding proteins. Getting in on the Akt. Cell. 2002;111(3):293\u2013303.","journal-title":"Cell"},{"issue":"6245","key":"7806_CR24","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/342082a0","volume":"342","author":"ML Toribio","year":"1989","unstructured":"Toribio ML, Gutierrez-Ramos JC, Pezzi L, Marcos MA, Martinez C. Interleukin-2-dependent autocrine proliferation in T-cell development. Nature. 1989;342(6245):82\u20135.","journal-title":"Nature."},{"issue":"5","key":"7806_CR25","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc2826","volume":"10","author":"N Shah","year":"2010","unstructured":"Shah N, Sukumar S. The Hox genes and their roles in oncogenesis. Nat Rev Cancer. 2010;10(5):361\u201371.","journal-title":"Nat Rev Cancer"},{"key":"7806_CR26","doi-asserted-by":"crossref","unstructured":"Luo Z, Rhie SK, Farnham PJ. The enigmatic HOX genes: can we crack their code? Cancers (Basel). 2019;11(3):323.","DOI":"10.3390\/cancers11030323"},{"issue":"10","key":"7806_CR27","doi-asserted-by":"publisher","first-page":"4759","DOI":"10.4049\/jimmunol.1201794","volume":"189","author":"DV Sawant","year":"2012","unstructured":"Sawant DV, Sehra S, Nguyen ET, Jadhav R, Englert K, Shinnakasu R, et al. Bcl6 controls the Th2 inflammatory activity of regulatory T cells by repressing Gata3 function. J Immunol. 2012;189(10):4759\u201369.","journal-title":"J Immunol"},{"issue":"23","key":"7806_CR28","doi-asserted-by":"publisher","first-page":"6153","DOI":"10.1182\/blood-2011-07-365320","volume":"118","author":"V Grossmann","year":"2011","unstructured":"Grossmann V, Tiacci E, Holmes AB, Kohlmann A, Martelli MP, Kern W, et al. Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype. Blood. 2011;118(23):6153\u201363.","journal-title":"Blood."},{"issue":"18","key":"7806_CR29","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1182\/blood-2012-11-469619","volume":"122","author":"F Damm","year":"2013","unstructured":"Damm F, Chesnais V, Nagata Y, Yoshida K, Scourzic L, Okuno Y, et al. BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders. Blood. 2013;122(18):3169\u201377.","journal-title":"Blood."},{"key":"7806_CR30","doi-asserted-by":"publisher","first-page":"14581","DOI":"10.1038\/ncomms14581","volume":"8","author":"M Lefebure","year":"2017","unstructured":"Lefebure M, Tothill RW, Kruse E, Hawkins ED, Shortt J, Matthews GM, et al. Genomic characterisation of Emu-Myc mouse lymphomas identifies Bcor as a Myc co-operative tumour-suppressor gene. Nat Commun. 2017;8:14581.","journal-title":"Nat Commun"},{"issue":"10","key":"7806_CR31","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1084\/jem.20170167","volume":"214","author":"T Tanaka","year":"2017","unstructured":"Tanaka T, Nakajima-Takagi Y, Aoyama K, Tara S, Oshima M, Saraya A, et al. Internal deletion of BCOR reveals a tumor suppressor function for BCOR in T lymphocyte malignancies. J Exp Med. 2017;214(10):2901\u201313.","journal-title":"J Exp Med"},{"issue":"4","key":"7806_CR32","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1158\/1078-0432.CCR-16-2071","volume":"23","author":"MG Cardenas","year":"2017","unstructured":"Cardenas MG, Oswald E, Yu W, Xue F, MacKerell AD Jr, Melnick AM. The expanding role of the BCL6 oncoprotein as a cancer therapeutic target. Clin Cancer Res. 2017;23(4):885\u201393.","journal-title":"Clin Cancer Res"},{"issue":"5134","key":"7806_CR33","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1126\/science.8235596","volume":"262","author":"BH Ye","year":"1993","unstructured":"Ye BH, Lista F, Lo Coco F, Knowles DM, Offit K, Chaganti RS, et al. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science. 1993;262(5134):747\u201350.","journal-title":"Science."},{"issue":"2","key":"7806_CR34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/ng0697-161","volume":"16","author":"BH Ye","year":"1997","unstructured":"Ye BH, Cattoretti G, Shen Q, Zhang J, Hawe N, de Waard R, et al. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet. 1997;16(2):161\u201370.","journal-title":"Nat Genet"},{"issue":"5","key":"7806_CR35","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1182\/blood-2006-06-028969","volume":"109","author":"L Lamant","year":"2007","unstructured":"Lamant L, de Reynies A, Duplantier MM, Rickman DS, Sabourdy F, Giuriato S, et al. Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes. Blood. 2007;109(5):2156\u201364.","journal-title":"Blood."},{"issue":"22","key":"7806_CR36","doi-asserted-by":"publisher","first-page":"10703","DOI":"10.1158\/0008-5472.CAN-07-1708","volume":"67","author":"PP Piccaluga","year":"2007","unstructured":"Piccaluga PP, Agostinelli C, Califano A, Carbone A, Fantoni L, Ferrari S, et al. Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. Cancer Res. 2007;67(22):10703\u201310.","journal-title":"Cancer Res"},{"issue":"3","key":"7806_CR37","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.coi.2013.04.003","volume":"25","author":"YS Choi","year":"2013","unstructured":"Choi YS, Yang JA, Crotty S. Dynamic regulation of Bcl6 in follicular helper CD4 T (Tfh) cells. Curr Opin Immunol. 2013;25(3):366\u201372.","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"7806_CR38","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/sj.leu.2401410","volume":"13","author":"H Kawagoe","year":"1999","unstructured":"Kawagoe H, Humphries RK, Blair A, Sutherland HJ, Hogge DE. Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells. Leukemia. 1999;13(5):687\u201398.","journal-title":"Leukemia."},{"issue":"11","key":"7806_CR39","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1038\/leu.2008.198","volume":"22","author":"M Andreeff","year":"2008","unstructured":"Andreeff M, Ruvolo V, Gadgil S, Zeng C, Coombes K, Chen W, et al. HOX expression patterns identify a common signature for favorable AML. Leukemia. 2008;22(11):2041\u20137.","journal-title":"Leukemia."},{"issue":"18","key":"7806_CR40","doi-asserted-by":"publisher","first-page":"4152","DOI":"10.1182\/blood-2011-09-382390","volume":"119","author":"K Ross","year":"2012","unstructured":"Ross K, Sedello AK, Todd GP, Paszkowski-Rogacz M, Bird AW, Ding L, et al. Polycomb group ring finger 1 cooperates with Runx1 in regulating differentiation and self-renewal of hematopoietic cells. Blood. 2012;119(18):4152\u201361.","journal-title":"Blood."},{"issue":"1","key":"7806_CR41","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1189\/jlb.0306170","volume":"81","author":"D Foell","year":"2007","unstructured":"Foell D, Wittkowski H, Vogl T, Roth J. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol. 2007;81(1):28\u201337.","journal-title":"J Leukoc Biol"},{"issue":"2","key":"7806_CR42","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nrc3893","volume":"15","author":"AR Bresnick","year":"2015","unstructured":"Bresnick AR, Weber DJ, Zimmer DB. S100 proteins in cancer. Nat Rev Cancer. 2015;15(2):96\u2013109.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"7806_CR43","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.neo.2018.09.007","volume":"20","author":"AK Brenner","year":"2018","unstructured":"Brenner AK, Bruserud O. S100 proteins in acute myeloid leukemia. Neoplasia. 2018;20(12):1175\u201386.","journal-title":"Neoplasia."},{"issue":"10","key":"7806_CR44","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00011-018-1173-4","volume":"67","author":"F Shabani","year":"2018","unstructured":"Shabani F, Farasat A, Mahdavi M, Gheibi N. Calprotectin (S100A8\/S100A9): a key protein between inflammation and cancer. Inflamm Res. 2018;67(10):801\u201312.","journal-title":"Inflamm Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-07806-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-021-07806-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-07806-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T07:06:08Z","timestamp":1670828768000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-07806-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,19]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["7806"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-07806-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,19]]},"assertion":[{"value":"18 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present study was approved by the Institutional Review Board in accordance with the Samsung Medical Center under the title \u201cIdentification of targeted therapeutic markers for malignant lymphoma (IRB No: 2015-01-034-001)\u201d. All patients provided written informed consent prior to study participation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}